plerixafor has been researched along with Cell Transformation, Neoplastic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bian, XW; Chen, JH; Cui, YH; Jiang, JY; Jiang, T; Lin, MC; Ping, YF; Qian, C; Wang, B; Wang, Jm; Yao, XH; Yu, SC; Zhang, R; Zhao, LT | 1 |
1 other study(ies) available for plerixafor and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
The chemokine CXCL12 and its receptor CXCR4 promote glioma stem cell-mediated VEGF production and tumour angiogenesis via PI3K/AKT signalling.
Topics: AC133 Antigen; Animals; Antigens, CD; Benzylamines; Cell Transformation, Neoplastic; Chemokine CXCL12; Cyclams; Gene Knockdown Techniques; Glioma; Glycoproteins; Heterocyclic Compounds; Humans; Mice; Mice, SCID; Neoplasm Proteins; Neoplastic Stem Cells; Neovascularization, Pathologic; Peptides; Phosphatidylinositol 3-Kinases; Platelet Endothelial Cell Adhesion Molecule-1; Receptors, CXCR4; RNA, Small Interfering; Signal Transduction; Tumor Stem Cell Assay; Vascular Endothelial Growth Factor A; Xenograft Model Antitumor Assays | 2011 |